Extended breakout or will it continue to run.
News on cancer. ir.intelliatx.com/ne...ical-data-supporting
Continued to run after public offering ir.intelliatx.com/ne...g-201-million-public
Nov started treating in clinical trial. ir.intelliatx.com/ne...-landmark-crisprcas9
Expanded collaboration with regeneron. ir.intelliatx.com/ne...ollaboration-develop
Business Seems to be firing on all cylinders.
Technically looks over extended.
Continued to run after public offering ir.intelliatx.com/ne...g-201-million-public
Nov started treating in clinical trial. ir.intelliatx.com/ne...-landmark-crisprcas9
Expanded collaboration with regeneron. ir.intelliatx.com/ne...ollaboration-develop
Business Seems to be firing on all cylinders.
Technically looks over extended.
Trade attivo:
>180 up since Dec. outpacing edit and crispr. still looks technically extended